I provide independent and original analysis, pricing metrics and recommendations for the stem, cell, gene and regenerative therapy equities.

Cytori (CYTX) 8.6 M share offering priced at $1.10 after stock jumps on BARDA news

April 10, 2017

  After a 25.55% (+$0.35) advance, CYTX launched a secondary offering.  Share pricing fell -34.30% (-$0.61) at the open  

Capricor Therapeutics (CAPR) at-the-market offering of $5 M

April 1, 2017

  CAPR closed up +$0.16 to $3.38, expect depreciation and dilution  

Roll Call

The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.